AstraZeneca Pharma India Limited — Updates, 02-09-2026: General Updates
02-09-2026 | 06:19 pm
02-09-2026 | 06:19 pm
AstraZeneca Pharma India secured an independent ESG rating of 64 from Crisil ESG Ratings. This external assessment, based on public information, offers insights into the company's environmental, social, and governance standing.
No comments yet. Be the first to comment!
